Multiple sclerosis

被引:234
作者
Hafler, DA
Slavik, JM
Anderson, DE
O'Connor, KC
De Jager, P
Baecher-Allan, C
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA
[3] MIT, Broad Inst, Cambridge, MA 02139 USA
[4] Harvard Univ, Cambridge, MA 02138 USA
关键词
D O I
10.1111/j.0105-2896.2005.00240.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) is a complex genetic disease associated with inflammation in the central nervous system (CNS) white matter and is thought to be mediated by autoimmune processes. Clonal expansion of B cells, their antibody products, and T cells, hallmarks of inflammation in the CNS, are found in MS. The association of the disease with major histocompatibility complex genes, the inflammatory white matter infiltrates, similarities with animal models, and the observation that MS can be treated with immunomodulatory and immunosuppressive therapies support the hypothesis that autoimmunity plays a major role in the disease pathology. This review discusses the immunopathology of MS with particular focus given to regulatory T cells and the role of B cells and antibodies, immunomodulatory therapeutics, and finally new directions in MS research, particularly new methods to define the molecular pathology of human disease with high-throughput examination of germline DNA haplotypes, RNA expression, and protein structures that will allow the generation of a new series of hypotheses that can be tested to develop better understandings and therapies for this disease.
引用
收藏
页码:208 / 231
页数:24
相关论文
共 211 条
[11]   Inhibition of human CD4+CD25+high regulatory T cell function [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6210-6217
[12]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[13]   OLIGODENDROCYTE-SPECIFIC EXPRESSION AND AUTOANTIGENICITY OF TRANSALDOLASE IN MULTIPLE-SCLEROSIS [J].
BANKI, K ;
COLOMBO, E ;
SIA, F ;
HALLADAY, D ;
MATTSON, DH ;
TATUM, AH ;
MASSA, PT ;
PHILLIPS, PE ;
PERL, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1649-1663
[14]   Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression [J].
Baranzini, SE ;
Elfstrom, C ;
Chang, SY ;
Butunoi, C ;
Murray, R ;
Higuchi, R ;
Oksenberg, JR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6576-6582
[15]  
Baranzini SE, 1999, J IMMUNOL, V163, P5133
[16]   FREQUENCY OF ANTINUCLEAR ANTIBODIES IN MULTIPLE-SCLEROSIS [J].
BARNED, S ;
GOODMAN, AD ;
MATTSON, DH .
NEUROLOGY, 1995, 45 (02) :384-385
[17]   Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro [J].
Becher, B ;
Dodelet, V ;
Fedorowicz, V ;
Antel, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (07) :1539-1543
[18]   Analysis of a sequenced cDNA library from multiple sclerosis lesions [J].
Becker, KG ;
Mattson, DH ;
Powers, JM ;
Gado, AM ;
Biddison, WE .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 77 (01) :27-38
[19]   THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS [J].
BENNUN, A ;
WEKERLE, H ;
COHEN, IR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) :195-199
[20]   Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event [J].
Berger, T ;
Rubner, P ;
Schautzer, F ;
Egg, R ;
Ulmer, H ;
Mayringer, I ;
Dilitz, E ;
Deisenhammer, F ;
Reindl, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :139-145